Grants & Projects per year
Personal profile
Biography
B.A., Chemistry and Mathematics, Humboldt State University, 1981
Ph.D. Massachusetts Institute of Technology, 1988
Helen Hay Whitney Fellowship, University of Oxford, 1988-1991
Postdoctoral Fellow, The DuPont Merck Co., 1991-1993
Pew Scholar in the Biomedical Sciences 1995-Present
Research interests
STRUCTURAL BIOLOGY
The research in our group is centered upon studies of protein folding, protein structure and the mechanism of amyloid formation. We want to understand how proteins fold to their final three dimensional structure and we want to understand why the folded conformation of proteins is stable. Our work on amyloid formation is directed towards understanding the physical basis for the pathological aggregation of polypeptides in certain diseases. These projects involve a wide range of techniques, including but not limited to: high resolution multidimensional NMR, protein design, stop flow methods, peptide synthesis and protein chemistry.
PROTEIN FOLDING
Elucidating how the amino acid sequence determines structure, the protein folding problem, is a central issue in modern structural biology. Our laboratory is currently studying the folding of two proteins, the ribosomal protein L9 and the E3/E1p-binding domain. A second area of interest is the nature of partially folded states of proteins. In recent years it has become clear that many proteins can exist in a partially folded state, known as the molten globule state, which contains a high degree of secondary structure but which lacks fixed tertiary interactions. We are studying the molten globule state formed by a small calcium binding protein, a-lactalbumin. Our studies of natural proteins are complemented by efforts in de novo protein design.
AMYLOID FORMATION
In certain diseases normally soluble proteins aggregate to form a dense structure called the amyloid fibril. Amyloid deposits are present in individuals suffering from type-II diabetes, Alzheimer's disease and in patients undergoing kidney dialysis. Little is known about the molecular mechanism of amyloid formation. We are studying amyloid formation by the polypeptides amylin and calcitonin. Amylinis a 37 residue peptide which forms amyloid deposits in type-II diabetes while calcitonin forms amyloid deposits in the thyroid. Our work involves the preparation of the peptides via solid phase peptide synthesis, the characterization of the structure of these molecules and studies of the kinetics of amyloid formation.
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Grants & Projects
- 25 Finished
-
Biophysical Studies of Amyloid Formation by Polypeptide Hormones
Raleigh, D. (PI)
National Institute of General Medical Sciences
09/25/21 → 06/30/26
Project: Research
-
Interaction of Amyloidogenic Proteins with Asymmetric Membranes
Raleigh, D. (PI)
08/15/17 → 07/31/22
Project: Research
-
Establishing a Long Island Bioscience Hub: REACH
Rubin, C. (PI), Anderson, B. (CoI), Bluestein, D. (CoI), Carpino, N. (CoI), Chen, J. (CoI), Del Poeta, M. (CoI), Dill, K. A. (CoI), Meng, Y. (CoI), Mujica-Parodi, L. R. (CoI), Parsons, R. G. (CoI), Qin, Y.-X. (CoI), Raleigh, D. (CoI), Stopeck, A. (CoI), Strey, H. H. (CoI), Tonge, P. (CoI), Abboud, M. (CoI), Ailawadi, S. (CoI), Baker, J. (CoI), Carino, P. (CoI), Daryaee, F. (CoI), Davis, J. (CoI), Dilmanian, A. (CoI), French, J. (CoI), Goldan, A. (CoI), Lubinsky, A. (CoI), Messina, C. (CoI), Rotman, O. (CoI), Sitharaman, B. (CoI), Smith-Jones, P. (CoI), Van Nostrand, W. (CoI), Yang, N. (CoI) & Zimmerman, T. (CoI)
National Heart Lung and Blood Institute
12/15/16 → 08/31/19
Project: Research
-
Biophysical Studies of Amyloid Formation by Polypeptide Hormones
Raleigh, D. (PI)
National Institute of General Medical Sciences
09/1/16 → 06/30/21
Project: Research
-
Structure, Dynamics and Energetics of Protein Unfolded States
Raleigh, D. (PI)
09/1/13 → 08/31/18
Project: Research
-
Aggregation kinetics define the temporal window of IAPP proteotoxicity
Plesner, A., Cao, P., Raleigh, D. P. & Abedini, A., Aug 11 2026, In: Proceedings of the National Academy of Sciences of the United States of America. 123, 32, e2615786123.Research output: Contribution to journal › Article › peer-review
Open Access -
Modulation of islet amyloid polypeptide induced β-cell toxicity and amyloid formation by serum albumin proteins
Zhyvoloup, A., Ridgway, Z., Prashanth, A. & Raleigh, D. P., Mar 2026, In: Biophysical Chemistry. 330, 107565.Research output: Contribution to journal › Article › peer-review
Open Access -
Trimethylammonium-diphenylhexatriene and propionic acid-diphenylhexatriene are sensitive fluorescence probes of amyloid formation by human IAPP
Lee, K. H., Manathunga, L., Li, M. H., London, E. & Raleigh, D. P., Jul 2026, In: Analytical Biochemistry. 714, 116096.Research output: Contribution to journal › Article › peer-review
-
Experimental and computational analysis of the basis for accelerated amyloid formation by a disease linked mutant of human islet amyloid polypeptide
Manathunga, L., Akter, R., Zou, J., Simmerling, C. & Raleigh, D. P., Nov 2025, In: Protein Science. 34, 11, e70308.Research output: Contribution to journal › Article › peer-review
Open Access -
On the importance of being amidated: Analysis of the role of the conserved C-terminal amide of amylin in amyloid formation and cytotoxicity
Yang, T., Filippov, I., Manathunga, L., Baghai, A., Maréchal, A., Raleigh, D. P. & Zhyvoloup, A., Apr 2024, In: Biophysical Chemistry. 307, 107168.Research output: Contribution to journal › Article › peer-review
Open Access8 Scopus citations